Search Results - "CAMPAGNOLO, D"

Refine Results
  1. 1

    Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis by MARRIE, R. A, RUDICK, R, HORWITZ, R, CUTTER, G, TYRY, T, CAMPAGNOLO, D, VOLLMER, T

    Published in Neurology (30-03-2010)
    “…Vascular comorbidity adversely influences health outcomes in several chronic conditions. Vascular comorbidities are common in multiple sclerosis (MS), but…”
    Get full text
    Journal Article
  2. 2

    Comorbidity delays diagnosis and increases disability at diagnosis in MS by MARRIE, R. A, HORWITZ, R, CUTTER, G, TYRY, T, CAMPAGNOLO, D, VOLLMER, T

    Published in Neurology (13-01-2009)
    “…Comorbidity is common in the general population and is associated with adverse health outcomes. In multiple sclerosis (MS), it is unknown whether preexisting…”
    Get full text
    Journal Article
  3. 3

    The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated by Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D, Vollmer, T

    Published in Multiple sclerosis (01-03-2009)
    “…Background Mental comorbidity is common in multiple sclerosis (MS), but some studies suggest that mental comorbidity may be underrecognized and undertreated…”
    Get full text
    Journal Article
  4. 4

    Comorbidity, socioeconomic status and multiple sclerosis by Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D, Vollmer, T

    Published in Multiple sclerosis (01-09-2008)
    “…Objective Multiple sclerosis (MS) is associated with substantial morbidity. The impact of comorbidity on MS is unknown, but comorbidity may explain some of the…”
    Get full text
    Journal Article
  5. 5

    Fully Automated Scan-to-BIM Via Point Cloud Instance Segmentation by Campagnolo, D., Camuffo, E., Michieli, U., Borin, P., Milani, S., Giordano, A.

    “…Digital reconstruction through Building Information Models (BIM) is a valuable methodology for documenting and analyzing existing buildings. Its pipeline…”
    Get full text
    Conference Proceeding
  6. 6

    High frequency of adverse health behaviors in multiple sclerosis by Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D, Vollmer, T

    Published in Multiple sclerosis (01-01-2009)
    “…Background Health behaviors influence chronic disease risks in the general population, and may influence health outcomes independently of comorbid diseases…”
    Get full text
    Journal Article
  7. 7

    Does multiple sclerosis-associated disability differ between races? by MARRIE, R. A, CUTTER, G, TYRY, T, VOLLMER, T, CAMPAGNOLO, D

    Published in Neurology (25-04-2006)
    “…To investigate differences in disability between African American and Caucasian patients with multiple sclerosis (MS) by comparing the relationship between…”
    Get full text
    Journal Article
  8. 8

    Validation of the NARCOMS registry: diagnosis by Marrie, R.A., Cutter, G., Tyry, T., Campagnolo, D., Vollmer, T.

    Published in Multiple sclerosis (01-07-2007)
    “…The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a patient registry, wherein the diagnoses of multiple sclerosis (MS) are…”
    Get full text
    Journal Article
  9. 9

    Disparities in the management of multiple sclerosis-related bladder symptoms by MARRIE, R. A, CUTTER, G, TYRY, T, VOLLMER, T, CAMPAGNOLO, D

    Published in Neurology (05-06-2007)
    “…Participants enrolled in the North American Research Committee on Multiple Sclerosis (NARCOMS) registry report disability status using Performance Scales (PS),…”
    Get full text
    Journal Article
  10. 10

    Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B by Mirandola, S., Campagnolo, D., Bortoletto, G., Franceschini, L., Marcolongo, M., Alberti, A.

    Published in Journal of viral hepatitis (01-07-2011)
    “…Drug resistance is a major limitation for the long‐term efficacy of antiviral therapy with nucleos(t)ide analogues (NAs) in chronic hepatitis B (CHB)…”
    Get full text
    Journal Article
  11. 11

    Altered innate immunity following spinal cord injury by Campagnolo, D I, Dixon, D, Schwartz, J, Bartlett, J A, Keller, S E

    Published in Spinal cord (01-07-2008)
    “…Study Design: Cross-sectional, paired cohort study. Objectives: To replicate the finding of impaired immunocyte function following spinal cord injury (SCI). To…”
    Get full text
    Journal Article
  12. 12

    Effect of maternal dietary counselling during the 1st year of life on glucose profile and insulin resistance at the age of 8 years: a randomised field trial by Costa, Cintia S., Campagnolo, Paula D. B., Lumey, L. H., Vitolo, Marcia R.

    Published in British journal of nutrition (14-01-2017)
    “…Education interventions that stimulate complementary feeding practices can improve the nutritional status of children and may protect against future chronic…”
    Get full text
    Journal Article
  13. 13

    CD4+ CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis by Jee, Y, Piao, W.H, Liu, R, Bai, X.F, Rhodes, S, Rodebaugh, R, Campagnolo, D.I, Shi, F.D, Vollmer, T.L

    Published in Clinical immunology (Orlando, Fla.) (01-10-2007)
    “…Abstract CD4+ CD25+ regulatory T cells (Tregs) are potent immunosuppressors that are pivotal in the maintenance of self-tolerance. The involvement of Tregs in…”
    Get full text
    Journal Article
  14. 14

    Association of MAOA and COMT gene polymorphisms with palatable food intake in children by Galvão, Ananda C.S, Krüger, Raquel C, Campagnolo, Paula D.B, Mattevi, Vanessa S, Vitolo, Márcia R, Almeida, Silvana

    Published in The Journal of nutritional biochemistry (01-03-2012)
    “…Several studies have implicated dopamine (DA) in appetite regulation. The enzymes catechol-o-methyltransferase (COMT) and monoamine oxidase A (MAOA) control DA…”
    Get full text
    Journal Article
  15. 15

    Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis by Vollmer, T, Panitch, H, Bar-Or, A, Dunn, J, Freedman, MS, Gazda, SK, Campagnolo, D, Deutsch, F, Arnold, DL

    Published in Multiple sclerosis (01-06-2008)
    “…Forty relapsing multiple sclerosis patients with 1–15 gadolinium (Gd)-enhancing lesions on screening brain magnetic resonance imaging (MRI) and Expanded…”
    Get full text
    Journal Article
  16. 16

    Changes in the ascertainment of multiple sclerosis by MARRIE, R. A, CUTTER, G, TYRY, T, HADJIMICHAEL, O, CAMPAGNOLO, D, VOLLMER, T

    Published in Neurology (11-10-2005)
    “…With diagnostic criteria alterations, increased MRI availability, and awareness of therapies, temporal changes in incidence and prevalence rates may occur,…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the association between the TAS1R2 and TAS1R3 variants and food intake and nutritional status in children by Melo, Silvia V, Agnes, Grasiela, Vitolo, Márcia R, Mattevi, Vanessa S, Campagnolo, Paula D B, Almeida, Silvana

    Published in Genetics and molecular biology (01-04-2017)
    “…Taste perception plays a key role in determining individual food preferences and dietary habits and may influence nutritional status. This study aimed to…”
    Get full text
    Journal Article
  18. 18

    Consumption of ultra-processed food products and its effects on children's lipid profiles: A longitudinal study by Rauber, F, Campagnolo, P.D.B, Hoffman, D.J, Vitolo, M.R

    “…Abstract Background and Aims Cardiovascular disease development is related to known risk factors (such as diet and blood lipids) that begin in childhood. Among…”
    Get full text
    Journal Article
  19. 19

    Ultra-processed food consumption and its effects on anthropometric and glucose profile: A longitudinal study during childhood by Costa, C.S., Rauber, F., Leffa, P.S., Sangalli, C.N., Campagnolo, P.D.B., Vitolo, M.R.

    “…Obesity and insulin resistance development are related to known risk factors (such as diet) that begin in childhood. Among dietary factors, the consumption of…”
    Get full text
    Journal Article
  20. 20

    Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS by Arnold, D. L., Campagnolo, D., Panitch, H., Bar-Or, A., Dunn, J., Freedman, M. S., Gazda, S. K., Vollmer, T.

    Published in Journal of neurology (01-10-2008)
    “…Background Glatiramer acetate (GA) therapy following brief, low-dose induction with mitoxantrone was safe and more effective than GA alone in suppressing…”
    Get full text
    Journal Article